Aaron J Yeoh1, Alison Pedley1, Klara J Rosenquist1, Udo Hoffmann1, Caroline S Fox1. 1. National Heart, Lung, and Blood Institute Framingham Heart Study (A.J.Y., A.P., K.J.R., C.S.F.), Framingham, Massachusetts 01702-5827; Division of Endocrinology and Metabolism (C.S.F.), Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Department of Radiology (U.H.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114.
Abstract
BACKGROUND: Alterations in the cellular characteristics of subcutaneous adipose tissue (SAT) may reduce its ability to expand in times of caloric excess, increasing the propensity to store excess calories viscerally (visceral adipose tissue [VAT]). We hypothesized (1) that increased SAT density, an indirect marker of fat quality, would be associated with an increased VAT/SAT ratio and increased cardiovascular disease (CVD) risk and (2) that these associations would be independent of the absolute volume of SAT. METHODS: We investigated the association of SAT density with the VAT/SAT ratio and CVD risk in 3212 participants (48% women, mean age, 50.7 years) from the Framingham Heart Study. Adipose tissue depot density and volume were quantified by computed tomography; traditional CVD risk factors were quantified. RESULTS: Higher SAT density was correlated with a higher VAT/SAT ratio in men (r = 0.17; P < .0001) but not in women (r = 0.04; P ≥ .05). More adverse levels of CVD risk factors were observed in the high SAT density/high VAT/SAT ratio group than in the referent group (low density/low ratio). For example, women had an increased risk of diabetes (odds ratio [OR], 6.7; 95% confidence interval [CI], 2.6-17.6; P = .0001) and hypertension (OR, 1.6; 95% CI, 1.1-2.4; P = .009). Additional adjustment for SAT volume generally strengthened these associations (diabetes OR, 10.8; 95% CI, 4.1-29.0; hypertension OR, 2.5; 95% CI, 1.7-3.7; all P < .0001). These trends were similar but generally weaker in men. CONCLUSION: High fat density, an indirect marker of fat quality, is associated with the propensity to store fat viscerally vs subcutaneously and is jointly characterized by an increased burden of CVD risk factors.
BACKGROUND: Alterations in the cellular characteristics of subcutaneous adipose tissue (SAT) may reduce its ability to expand in times of caloric excess, increasing the propensity to store excess calories viscerally (visceral adipose tissue [VAT]). We hypothesized (1) that increased SAT density, an indirect marker of fat quality, would be associated with an increased VAT/SAT ratio and increased cardiovascular disease (CVD) risk and (2) that these associations would be independent of the absolute volume of SAT. METHODS: We investigated the association of SAT density with the VAT/SAT ratio and CVD risk in 3212 participants (48% women, mean age, 50.7 years) from the Framingham Heart Study. Adipose tissue depot density and volume were quantified by computed tomography; traditional CVD risk factors were quantified. RESULTS: Higher SAT density was correlated with a higher VAT/SAT ratio in men (r = 0.17; P < .0001) but not in women (r = 0.04; P ≥ .05). More adverse levels of CVD risk factors were observed in the high SAT density/high VAT/SAT ratio group than in the referent group (low density/low ratio). For example, women had an increased risk of diabetes (odds ratio [OR], 6.7; 95% confidence interval [CI], 2.6-17.6; P = .0001) and hypertension (OR, 1.6; 95% CI, 1.1-2.4; P = .009). Additional adjustment for SAT volume generally strengthened these associations (diabetes OR, 10.8; 95% CI, 4.1-29.0; hypertension OR, 2.5; 95% CI, 1.7-3.7; all P < .0001). These trends were similar but generally weaker in men. CONCLUSION: High fat density, an indirect marker of fat quality, is associated with the propensity to store fat viscerally vs subcutaneously and is jointly characterized by an increased burden of CVD risk factors.
Authors: A Gastaldelli; A M Sironi; D Ciociaro; V Positano; E Buzzigoli; D Giannessi; M Lombardi; A Mari; E Ferrannini Journal: Diabetologia Date: 2005-08-06 Impact factor: 10.122
Authors: Greta Lee Splansky; Diane Corey; Qiong Yang; Larry D Atwood; L Adrienne Cupples; Emelia J Benjamin; Ralph B D'Agostino; Caroline S Fox; Martin G Larson; Joanne M Murabito; Christopher J O'Donnell; Ramachandran S Vasan; Philip A Wolf; Daniel Levy Journal: Am J Epidemiol Date: 2007-03-19 Impact factor: 4.897
Authors: Bret H Goodpaster; Shanthi Krishnaswami; Tamara B Harris; Andreas Katsiaras; Steven B Kritchevsky; Eleanor M Simonsick; Michael Nevitt; Paul Holvoet; Anne B Newman Journal: Arch Intern Med Date: 2005-04-11
Authors: P Maurovich-Horvat; J Massaro; C S Fox; F Moselewski; C J O'Donnell; U Hoffmann Journal: Int J Obes (Lond) Date: 2006-09-05 Impact factor: 5.095
Authors: Caroline S Fox; Joseph M Massaro; Udo Hoffmann; Karla M Pou; Pal Maurovich-Horvat; Chun-Yu Liu; Ramachandran S Vasan; Joanne M Murabito; James B Meigs; L Adrienne Cupples; Ralph B D'Agostino; Christopher J O'Donnell Journal: Circulation Date: 2007-06-18 Impact factor: 29.690
Authors: Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante Journal: J Clin Invest Date: 2003-12 Impact factor: 14.808
Authors: K Chughtai; Y Song; P Zhang; B Derstine; E Gatza; J Friedman; L Hully; C Inglis; S Goldstein; J Magenau; A Pawarode; P Reddy; M Riwes; G Yanik; S C Wang; S W Choi Journal: Bone Marrow Transplant Date: 2015-11-09 Impact factor: 5.483
Authors: Ruban Dhaliwal; John A Shepherd; Laure El Ghormli; Kenneth C Copeland; Mitchell E Geffner; Janine Higgins; Lynne L Levitsky; Kristen J Nadeau; Ruth S Weinstock; Neil H White Journal: Diabetes Care Date: 2019-06-05 Impact factor: 19.112
Authors: Jordan E Lake; Carlee Moser; Liz Johnston; Clara Magyar; Scott D Nelson; Kristine M Erlandson; Todd T Brown; Grace A McComsey Journal: J Clin Endocrinol Metab Date: 2019-10-01 Impact factor: 5.958
Authors: A Michaud; J Tordjman; M Pelletier; Y Liu; S Laforest; S Noël; G Le Naour; C Bouchard; K Clément; A Tchernof Journal: Int J Obes (Lond) Date: 2016-10-04 Impact factor: 5.095
Authors: Ravi V Shah; M A Allison; J A C Lima; S A Abbasi; A Eisman; C Lai; M Jerosch-Herold; M Budoff; V L Murthy Journal: Nutr Metab Cardiovasc Dis Date: 2015-12-28 Impact factor: 4.222
Authors: J E Lake; P Debroy; D Ng; K M Erlandson; L A Kingsley; F J Palella; M J Budoff; W S Post; T T Brown Journal: Eur J Endocrinol Date: 2019-10 Impact factor: 6.664
Authors: Jane J Lee; Alison Pedley; Udo Hoffmann; Joseph M Massaro; John F Keaney; Ramachandran S Vasan; Caroline S Fox Journal: J Am Heart Assoc Date: 2016-02-29 Impact factor: 5.501